Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals

Journal of Leukocyte Biology

Volumn 94, Issue 5, 2013, Pages 1051-1059

  Raposo, Rui André Saraiva ^a   Abdel Mohsen, Mohamed ^a   Holditch, Sara J ^a   Kuebler, Peter J ^a   Cheng, Rex G ^a   Eriksson, Emily M ^a   Liao, Wilson ^a   Pillai, Satish K ^a,b,c   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

HIV 1; HLA class I; Restriction factors

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3C; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3D; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3H; BST 2 PROTEIN; HLA B35 ANTIGEN; HLA B57 ANTIGEN; ISG15 PROTEIN; PROTEIN; PROTEIN P21; TETHERIN; TRIPARTITE MOTIF PROTEIN 22; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL PARAMETERS; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

HIV-1; HLA CLASS I; RESTRICTION FACTORS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4-POSITIVE T-LYMPHOCYTES; CYTIDINE DEAMINASE; FEMALE; HIV-1; HLA-B ANTIGENS; HLA-B35 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; PROTEINS; RECEPTORS, CCR5; RECEPTORS, HIV;

EID: 84887012592     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0313150     Document Type: Article

References (44)

1. Gao, X., O'Brien, T. R., Welzel, T. M., Marti, D., Qi, Y., Goedert, J. J., Phair, J., Pfeiffer, R., Carrington, M. (2010) HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS 24, 1835-1840.
2. Altfeld, M., Kalife, E. T., Qi, Y, Streeck, H., Lichterfeld, M., Johnston, M. N., Burgett, N., Swartz, M. E., Yang, A., Alter, G., Yu, X. G., Meier, A, Rockstroh, J. K, Allen, T. M., Jessen, H., Rosenberg, E. S., Carrington, M., Walker, B. D. (2006) HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med. 3, e403.
3. Gao, X., Bashirova, A., Iversen, A. K, Phair, J., Goedert, J. J., Buch-binder, S., Hoots, K, Vlahov, D., Altfeld, M., O'Brien, S. J., Carrington, M. (2005) AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med 11, 1290-1292.
4. Altfeld, M., Addo, M. M., Rosenberg, E. S., Hecht, F. M., Lee, P. K, Vo-gel, M., Yu, X. G., Draenert, R, Johnston, M. N., Strick, D., Allen, T. M., Feeney, M. E., Kahn, J. O., Sekaly, R P., Levy, J. A., Rockstroh, J. K, Goulder, P. J., Walker, B. D. (2003) Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17, 2581-2591.
5. Stewart-Jones, G. B., Gillespie, G., Overton, I. M., Kaul, R, Roche, P., McMichael, A. J., Rowland-Jones, S., Jones, E. Y (2005) Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J. Immunol. 175, 2459-2468.
6. Huang, J., Goedert, J. J., Sundberg, E. J., Cung, T. D., Burke, P. S., Martin, M. P., Preiss, L., Lifson, J., Lichterfeld, M., Carrington, M., Yu, X. G (2009) HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses.J. Exp. Med. 206, 2959-2966.
7. Willberg, C. B., Garrison, K. E., Jones, R B., Meiklejohn, D. J., Spotts, G., Liegler, T. J., Ostrowski, M. A., Karlsson, A. C, Hecht, F. M., Nixon, D. F. (2010) Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes. PLoS One 5, e10249.
8. Jansen, C. A., Kostense, S., Vandenberghe, K, Nanlohy, N. M., De Cuyper, I. M., Piriou, E., Manting, E. H., Miedema, F., van Baarle, D. (2005) High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection. Eur. J. Immunol. 35, 150-158.
9. Migueles, S. A., Laborico, A. C, Imamichi, H., Shupert, W. L., Royce, C, McLaughlin, M., Ehler, L., Metcalf, J., Liu, S., Hallahan, C. W., Connors, M. (2003) The differential ability of HLA B*5701+ long-term non-progressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J. Virol. 77, 6889-6898.
10. Gillespie, G. M., Kaul, R, Dong, T., Yang, H. B., Rostron, T., Bwayo, J. J., Kiama, P., Peto, T., Plummer, F. A., McMichael, A. J., Rowland-Jones, S. L. (2002) Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 16, 961-972.
11. Vigneault, F., Woods, M., Buzon, M. J., Li, C, Pereyra, F., Crosby, S. D., Rychert, J., Church, G., Martinez-Picado, J., Rosenberg, E. S., Telenti, A, Yu, X. G., Lichterfeld, M. (2011) Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J. Virol. 85, 3015-3019.
12. Rotger, M., Dang, K K, Fellay, J., Heinzen, E. L., Feng, S., Descombes, P., Shianna, K. V., Ge, D., Gunthard, H. F., Goldstein, D. B., Telenti, A. (2010) Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog. 6, e1000781.
13. Harris, R. S., Bishop, K N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K, Watt, I. N., Neuberger, M. S., Malim, M. H. (2003) DNA deamina-tion mediates innate immunity to retroviral infection. Cell 113, 803-809.
14. Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., Trono, D. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424, 99-103.
15. Berger, G., Durand, S., Fargier, G., Nguyen, X. N., Cordeil, S., Bouaziz, S., Muriaux, D., Darlix, J. L., Cimarelli, A. (2011) APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 7, e1002221.
16. Van Manen, D., Rits, M. A, Beugeling, C, van Dort, K., Schuitemaker, H., Kootstra, N. A. (2008) The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS. Pathog. 4, e18.
17. Neil, S. J., Zang, T., Bieniasz, P. D. (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
18. Guatelli, J. C. (2009) Interactions of viral protein U (Vpu) with cellular factors. Curr. Top. Microbiol. Immunol. 339, 27-45.
19. Pincetic, A, Kuang, Z., Seo, E. J., Leis, J. (2010) The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 84, 4725-4736.
20. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C, Segeral, E., Yatim, A, Emiliani, S., Schwartz, O., Benkirane, M. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657.
21. Leavy, O. (2011) Antiviral immunity: SAMHD1-stopping HIV in its tracks. Nat. Rev. Immunol. 11, 440.
22. Chen, H., Li, C, Huang, J., Cung, T., Seiss, K, Beamon, J., Carrington, M. F., Porter, L. C, Burke, P. S., Yang, Y, Ryan, B. J., Liu, R, Weiss, R H., Pereyra, F., Cress, W. D., Brass, A. L., Rosenberg, E. S., Walker, B. D., Yu, X. G., Lichterfeld, M. (2011) CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J. Clin. Invest. 121, 1549-1560.
23. Vandesompele, J., De Preter, K, Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A, Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034.
24. Refsland, E. W., Stenglein, M. D., Shindo, K, Albin, J. S., Brown, W. L., Harris, R S. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38, 4274-4284.
25. Hunt, P. W., Brenchley, J., Sinclair, E., McCune, J. M., Roland, M., Page-Shafer, K, Hsue, P., Emu, B., Krone, M., Lampiris, H., Douek, D., Martin, J. N., Deeks, S. G. (2008) Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J. Infect. Dis. 197, 126-133.
26. Homann, S., Smith, D., Little, S., Richman, D., Guatelli, J. (2011) Up-regulation of BST-2/tetherin by HIV infection in vivo. J. Virol. 85, 10659-10668.
27. Vicenzi, E., Poli, G. (2013) Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro. Tissue Antigens 81, 61-71.
28. Peng, G., Greenwell-Wild, T., Nares, S., Jin, W., Lei, K. J., Rangel, Z. G., Munson, P. J., Wahl, S. M. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110, 393-400.
29. Sajadi, M. M., Pulijala, R, Redfield, R R, Talwani, R (2012) Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors. AIDS 26, 1879-1884.
30. Pillai, S. K, Abdel-Mohsen, M., Guatelli, J., Skasko, M., Monto, A, Fu-jimoto, K, Yukl, S., Greene, W. C, Kovari, H., Rauch, A, Fellay, J., Bat in the interferon-a-mediated suppression of HIV-1 in vivo. Proc. Natl. Acad. Sci. USA 109, 3035-3040.
31. Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E. C, Dragin, L., Bloch, N., Maudet, C, Bertrand, M., Gramberg, T., Pancino, G, Priet, S., Canard, B., Laguette, N., Benkirane, M., Transy, C, Landau, N. R, Kim, B., Margottin-Goguet, F. (2012) SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 13, 223-228.
32. St Gelais, C, de Silva, S., Amie, S. M., Coleman, C. M., Hoy, H., Hollen-baugh, J. A, Kim, B., Wu, L. (2012) SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interfer-ons. Retrovirology 9, 105.
33. Descours, B., Cribier, A, Chable-Bessia, C, Ayinde, D., Rice, G., Crow, Y, Yatim, A, Schwartz, O., Laguette, N., Benkirane, M. (2012) SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 9, 87.
34. Wu, L. (2012) SAMHD1: a new contributor to HIV-1 restriction in resting CD4+ T-cells. Retrovirology 9, 88.
35. Dean, M., Carrington, M., Winkler, C, Huttley, G. A, Smith, M. W., Al-likmets, R, Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R, Saah, A, Rinaldo, C, Detels, R, O'Brien, S. J. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273, 1856-1862.
36. Huang, Y, Paxton, W. A, Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K, Kunstman, K., Erickson, D., Dragon, E., Landau, N. R, Phair, J., Ho, D. D., Koup, R A. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2, 1240-1243.
37. Marmor, M., Sheppard, H. W., Donnell, D., Bozeman, S., Celum, C, Buchbinder, S., Koblin, B., Seage G. R (2001) Homozygous and heterozygous CCR5-A32 genotypes are associated with resistance to HIV infection. J. Acquir. Immune Defic. Syndr. 27, 472-481.
38. Wu, L., Paxton, W. A, Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R A, Mackay, C. R. (1997) CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp. Med. 185, 1681-1691.
39. Venkatesan, S., Petrovic, A, Van Ryk, D. I., Locati, M., Weissman, D., Murphy, P. M. (2002) Reduced cell surface expression of CCR5 in CCR5A 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol. Chem. 277, 2287-2301.
40. Hummel, S., Schmidt, D., Kremeyer, B., Herrmann, B., Oppermann, M. (2005) Detection of the CCR5-A32 HIV resistance gene in Bronze Age skeletons. Genes Immun. 6, 371-374.
41. Lucotte, G. (2002) Frequencies of 32 base pair deletion of the (A 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis. Infect. Genet. Evol. 1, 201-205.
42. Gonzalez-Galarza, F. F., Christmas, S., Middleton, D., Jones, A. R (2011) Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 39, D913-D919.
43. Wilson, P. B., Bohjanen, K. A, Ingraham, S. J., Leon, A. S. (2012) Psoriasis and physical activity: a review. J. Eur. Acad. Dermatol. Venereol. 26, 1345-1353.
44. Chen, H., Hayashi, G., Lai, O. Y, Dilthey, A, Kuebler, P. J., Wong, T. V., Martin, M. P., Fernandez Vina, M. A, McVean, G., Wabl, M., Leslie, K. S., Maurer, T., Martin, J. N., Deeks, S. G., Carrington, M., Bow-cock, A. M., Nixon, D. F., Liao, W. (2012) Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. PLoS Genet. 8, e1002514.